Dynamic Technology Lab’s Sarepta Therapeutics SRPT Stock Holding History

Dynamic Technology Lab’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,370	Closed	-$1.08M	–	1488
2022 Q4	$1.08M	Buy	+8,370	New	+$970K	0.11%	308
2022 Q2	–	Sell	-12,240	Closed	-$956K	–	1511
2022 Q1	$956K	Buy	+12,240	New	+$937K	0.11%	305
2021 Q3	–	Sell	-3,710	Closed	-$288K	–	1445
2021 Q2	$288K	Buy	+3,710	New	+$281K	0.03%	807
2019 Q2	–	Sell	-7,478	Closed	-$891K	–	1261
2019 Q1	$891K	Buy	+7,478	New	+$961K	0.15%	215
2018 Q2	–	Sell	-3,792	Closed	-$281K	–	1295
2018 Q1	$281K	Buy	+3,792	New	+$253K	0.04%	738
2017 Q3	–	Sell	-6,462	Closed	-$218K	–	1354
2017 Q2	$218K	Sell	6,462 -576	-8%	-$18.8K	0.04%	845
2017 Q1	$209K	Buy	+7,038	New	+$218K	0.05%	774

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynamic Technology Lab's SRPT Position: Q1 2023 in Review

Dynamic Technology Lab sold out of Sarepta Therapeutics (SRPT) in Q1 2023, closing a stake of 8,370 shares — an estimated $1.08M sold.

Dynamic Technology Lab first reported a position in SRPT in Q1 2017 and held it in 7 quarters. The position peaked at $1.08M in Q4 2022. 425 funds tracked by Wall St. Rank hold SRPT as of Q1 2023.

Dynamic Technology Lab reported no remaining Sarepta Therapeutics position as of Q1 2023 after selling out during the quarter.
Dynamic Technology Lab sold 8,370 Sarepta Therapeutics shares in Q1 2023, an estimated $1.08M.
Dynamic Technology Lab first reported a position in Sarepta Therapeutics in Q1 2017 and held it in 7 quarters.
Dynamic Technology Lab's Sarepta Therapeutics position peaked at $1.08M in Q4 2022.
425 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2023.

Based on Dynamic Technology Lab's 13F filing for Q1 2023, filed 12 May 2023.